Sevenfact
| Product Specs | Description |
|---|---|
| Manufacturer Name | HEMA Biologics |
| Indications | Treatment and control of bleeding episodes occurring in adults and adolescents (12 years of age and older) with hemophilia A or B with inhibitors |
| Contraindications | Patients who have known allergy to rabbits or rabbit proteins OR patients who have severe hypersensitivity reaction to SEVENFACT or any of its components. |
| Viral Safety Process | The production process includes various purification, virus removal/inactivation and filtration steps that ensure the safety of the medicinal products. |
| Product Half-Life | 1.6 hours |
| Manufacturing Method | Recombinant |
| Storage Requirements/Shelf Life |
|
| Nominal Vial Size & Diluent Volume | Approximately 1 mg of sterile water per mL SEVENFACT (1000 micrograms per mL) |